Hunan Fangsheng Pharmaceutical Co., Ltd. Stock: price and insider trades · China
方盛制药
No insider purchase over the last 90 days. The latest, by 张祖嵘, was filed 13 May 2025.
Hunan Fangsheng Pharmaceutical Co., Ltd.: what insiders have been doing
Every trade that managers of Hunan Fangsheng Pharmaceutical Co., Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. The past year has been quiet: not a single insider filing for Hunan Fangsheng Pharmaceutical Co., Ltd. The previous disclosure was published on 13 May 2025.
Over the whole record (from 2023), the tally stands at 10 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and Vetoquinol SA. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +11.3%Entry CN¥9.61 · Close at T+365 CN¥10.70
- -7.2%Entry CN¥11.63 · Close at T+365 CN¥10.79
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 413,300 shares97.5% of flowA股XSHGSSE:173000008947685700Canonical exit: 11 Aug 2025 (T+90)
- 10,000 shares2.5% of flowA股XSHGSSE:173000008534553000Canonical exit: 12 May 2025 (T+90)
- 17,400 shares29.0% of flowA股XSHGSSE:173000007715424800Canonical exit: 1 Sept 2024 (T+90)
- 3,000 shares5.0% of flowA股XSHGSSE:173000007702092800Canonical exit: 28 Aug 2024 (T+90)
- 19,000 shares31.4% of flowA股XSHGSSE:173000007553186780Canonical exit: 25 Jul 2024 (T+90)
- 1,000 shares1.7% of flowA股XSHGSSE:173000007543172000Canonical exit: 24 Jul 2024 (T+90)
- 1,000 shares1.6% of flowA股XSHGSSE:173000007534840540Canonical exit: 23 Jul 2024 (T+90)
- 10,000 shares14.5% of flowA股XSHGSSE:173000007190078370Canonical exit: 26 Mar 2024 (T+90)
- 1,000 shares1.5% of flowA股XSHGSSE:173000007190078340Canonical exit: 25 Mar 2024 (T+90)
- 10,000 shares15.4% of flowA股XSHGSSE:173000007180669820Canonical exit: 21 Mar 2024 (T+90)
10 of 10 declarations
About Hunan Fangsheng Pharmaceutical Co., Ltd.
Fangsheng Pharmaceutical is a company operating in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the research, development, and production of innovative medicines.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
